UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010508
Receipt number R000012291
Scientific Title Investigation of allergic reaction during the treatment of anti-TNF alpha monoclonal antibody in patients with inflammatory bowel diseases
Date of disclosure of the study information 2013/05/01
Last modified on 2018/01/02 21:50:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of allergic reaction during the treatment of anti-TNF alpha monoclonal antibody in patients with inflammatory bowel diseases

Acronym

Investigation of allergic reaction in anti-TNF alpha monoconal antibody- treatment

Scientific Title

Investigation of allergic reaction during the treatment of anti-TNF alpha monoclonal antibody in patients with inflammatory bowel diseases

Scientific Title:Acronym

Investigation of allergic reaction in anti-TNF alpha monoconal antibody- treatment

Region

Japan


Condition

Condition

inflammatory boewl diseases

Classification by specialty

Medicine in general Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of prognostic biomarker for detection of allergic reaction of anti-TNF alpha monoclonal antibody

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Investigation of biomarker

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine Other

Interventions/Control_1

Allergic group for anti-TNF aplha monoclonal antibody

Interventions/Control_2

non allergic group for anti-TNF aplha monoclonal antibody

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

IBD patients who had or will have a informed consent of clinical study of UMIN000005032

Key exclusion criteria

Patients without informed consent

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shingo Kato

Organization

Saitama Medical Center, Saitama Medical University

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

1981 Kamoda, Kawagoe, Saitama 350-8550, Japan

TEL

049-228-3564

Email

skato@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shingo Kato

Organization

Saitama Medical Center, Saitama Medical University

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

1981 Kamoda, Kawagoe, Saitama 350-8550, Japan

TEL

049-228-3564

Homepage URL


Email

skato@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical Center, Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical Center, Saitama Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 04 Month 16 Day

Last modified on

2018 Year 01 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012291


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name